Hexo Corp: Multiple Analysts Lower Price Targets Following Fourth Quarter Earnings
This morning, Canaccord Genuity lowered their 12-month price target on Hexo Corp (TSX: HEXO) (NYSE: HEXO) to C$1.00 from C$1.50
Read moreThis morning, Canaccord Genuity lowered their 12-month price target on Hexo Corp (TSX: HEXO) (NYSE: HEXO) to C$1.00 from C$1.50
Read moreHexo Corp (TSX: HEXO) (NYSE: HEXO) this morning finally announced the inevitable – the company has proposed a share consolidation.
Read moreHexo Corp (TSX: HEXO) (NASDAQ: HEXO) reported its fourth quarter earnings this evening, reporting net revenues of $27.1 million for
Read moreHexo Corp (TSX: HEXO) (NYSE: HEXO) this evening announced that Trent MacDonald as been named as “acting” chief financial officer
Read moreRecently, Cantor Fitzgerald released their monthly review of Hifyre data for the four weeks ending September 19th. In the summary,
Read moreThe revolving door that is the chief financial officer position at Hexo Corp (TSX: HEXO) (NYSE: HEXO) has claimed another.
Read moreHexo Corp (TSX: HEXO) (NYSE: HEXO) has seen its joint venture with Molson Coors Canada, Truss Beverages, begin to roll
Read moreHexo Corp (TSX: HEXO) (NYSE: HEXO) this morning announced that it has stopped flooding the market with its paper as
Read moreHexo Corp (TSX: HEXO) (NYSE: HEXO) has gone international in a bid to offload some of its product. The company
Read moreIt appears that Hexo Corp (TSX: HEXO) (NYSE: HEXO) has filed a counterclaim against Medipharm Labs (TSX: LABS) in relation
Read more